JULIA JASTER: Open Payments
NPI 1215761119 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,993 in 307 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $607 · 2025 $3,993
Food & beverage: $3,981Education: $12
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 55 | $871 |
| Vanda Pharmaceuticals Inc. | 63 | $475 |
| Lundbeck LLC | 30 | $458 |
| ABBVIE INC. | 28 | $412 |
| Otsuka America Pharmaceutical, Inc. | 25 | $403 |
| Collegium Pharmaceutical, Inc. | 26 | $251 |
| Neurocrine BioSciences, Inc. | 11 | $224 |
| Supernus Pharmaceuticals, Inc. | 23 | $217 |
| HARMONY BIOSCIENCES LLC | 11 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $187 |
Products named: Auvelity, REXULTI, FANAPT, VRAYLAR, Jornay PM, INGREZZA, Qelbree, WAKIX.
Industry payments across WI — which companies pay providers there.
